NCT05521451Recruiting
Clinical Cohort Study - TRUST
Longterm Outcome and Predictors for Recurrence After Medical and Interventional Treatment of Arrhythmias At the University Heart Center Hamburg
Source: ClinicalTrials.gov · Last updated 30 Mar 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 22 Aug 2022
- Start date
- 17 Mar 2021
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Universitätsklinikum Hamburg-Eppendorf
- Diseases
- Atrial fibrillation
- NCT number
- NCT05521451
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 17 Mar 2021 to the primary completion date, 30 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study design.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Insufficient knowledge of the German language to understand study documents and interview without translation
- Physical or psychological incapability to cooperate in the investigation
Who the study is looking for
- Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia
- Age ≥ 18 years
- Written informed consent
- Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University Hospital Hamburg-Eppendorf, University Heart and Vascular Center Coordinator of this site? Confirm its status | Hamburg | Germany | Recruiting |
Related publications
- Pulmonary vein isolation and beyond: Feasibility and acute outcomes of the lattice-tip dual-energy catheter for complex ablations.Heart Rhythm O2 · 2026 · PMID 41732243
This page is information, not medical advice. Discuss any trial with your doctor.